Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$22.1

Avg closing price
Price range

2 Sands Capital Spruce Biosciences Trades

Sands Capital started to build up the position in Spruce Biosciences in Q4 2020. Since then they sold 787 Thousand shares. The investor sold all their shares in Q3 2021 and doesn't own any shares in Spruce Biosciences anymore.

Avg closing price
Price range
Sold -787 Thousand shares Q3 2021
Avg closing price $8.37
Price range $6.01 - $11.26
New holding (+787 Thousand shares) Q4 2020
Avg closing price $22.10
Price range $15.38 - $32.42

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!